The original preparation Mildronate® GX of Grindeks has received the prestigious award and nomination “The Cardiological Medication of the Year” in the awarding ceremony of...
From October 25 to 27, JSC Grindeks will participate in the international exhibition “CPhI Worldwide 2011” in Messe Frankfurt, Germany. During the exhibition Grindeks will...
Active pharmaceutical ingredients UDCA* manufacturing unit is one of Grindeks most significant investment projects. The total contribution of the new manufacturing unit consists of 6.34...
Grindeks informs that starting this autumn in Latvian pharmacies will once again be offered the company`s manufactured vitamins. Vitamin Gritamin® series will have six products...
JSC Grindeks informs that today, on 29 March, the company is visited by the representatives of the European Commission, the Latvian Investment and Development Agency...
Joint-stock company Grindeks informs that it has established a new anti-cancer final dosage forms’ manufacturing unit, in which 400 thousand lats have been invested. Production...
JSC Grindeks informs that the company successfully continues registration of Mildronate® in the People’s Republic of China. Last week in China, Beijing Grindeks management representatives...
JSC Grindeks informs that, reviewing the Group’s further development, manufacturing plant establishment in Russia is being considered as one of the options. No decisions have...
On 9 December 2010 in the contest “Export and Innovation Award 2010” organized by the Ministry of Economics of the Republic of Latvia and Investment...
Referring to the information, published at the news portal BNS, JSC Grindeks confirms that expansion of cooperation with the Latvian Institute of Organic Synthesis is...
From October 5 to 7, JSC Grindeks will participate in the international exhibition “CPhI Worldwide 2010” in Paris Nord Villepinte, France. During the exhibition Grindeks...
